NovoCure Ltd·4

Nov 4, 4:09 PM ET

Leonard Frank X 4

4 · NovoCure Ltd · Filed Nov 4, 2025

Insider Transaction Report

Form 4
Period: 2025-11-01
Leonard Frank X
Chief Executive Officer
Transactions
  • Tax Payment

    Ordinary Shares

    [F1]
    2025-11-01$12.81/sh966$12,374347,745 total
Footnotes (1)
  • [F1]Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).
Signature
Steven Robbins, as attorney in fact for Leonard, Frank X.|2025-11-04

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT